The Efficacy of Pasteurised Akkermansia Muciniphila in Healthy Medical Workers

NACompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

March 10, 2025

Study Completion Date

March 10, 2025

Conditions
StressHealthyDietary Supplement
Interventions
DIETARY_SUPPLEMENT

Pasteurized Akkermansia muciniphila

PAM supplementation; packaging will be given to the subjects every one month during follow-up visits, with the instructions to take one dose every morning on an empty stomach

DIETARY_SUPPLEMENT

Placebo

PBO administration; packaging will be given to the subjects every one month during follow-up visits, with the instructions to take one dose every morning on an empty stomach

Trial Locations (2)

70-210

Pomeranian Medical University in Szczecin, Szczecin

71-240

Center fo Medical Simulation, Szczecin

All Listed Sponsors
collaborator

SANPROBI SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA SPOLKA KOMANDYTOWA

UNKNOWN

collaborator

THE AKKERMANSIA COMPANY

UNKNOWN

collaborator

Charite University, Berlin, Germany

OTHER

collaborator

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC) - MDC

UNKNOWN

collaborator

Imperial College London

OTHER

lead

Pomeranian Medical University Szczecin

OTHER

NCT05738746 - The Efficacy of Pasteurised Akkermansia Muciniphila in Healthy Medical Workers | Biotech Hunter | Biotech Hunter